Theraclion Quote - ALTHE

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.332

Bid

0.333

Offer

0.334

Volume

11,376

0.332 Day's Range 0.341

0.286 52 Week Range 0.68

Market Cap

15.183M

Previous Close

0.341

Open

0.341

Last Trade

0.332

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

12,478

Shares Outstanding

45,732,250

Dividend Yield

PE Ratio

-4.10

Earnings Per Share (EPS)

-0.08

Revenue

3.92M

Net Profit

-3.68M

Sector

Med, Dental, Hosp Eq-whsl

Industry

Med, Dental, Hosp Eq-whsl

Website

www.theraclion.com

Headquarters

Malakoff, Hauts-de-seine, Fra

Founded

Theraclion is listed in the Med, Dental, Hosp Eq-whsl sector of the Euronext with ticker ALTHE. The last closing price for Theraclion was 0.34 €. Over the last year, Theraclion shares have traded in a share price range of 0.286 € to 0.68 €.

Theraclion currently has 45,732,250 shares in issue. The market capitalisation of Theraclion is 15.59 € million. Theraclion has a price to earnings ratio (PE ratio) of -4.10.

THERACLION MARQUE DES AVANCÉES MAJEURES ET ANNONCE SES RÉSULTATS FINANCIERS DU PREMIER SEMESTRE

Fort de ses avancées sur ses priorités de 2023 et 2024 - accès au marché américain, R&D et Chine - Theraclion planifie sa montée en puissance commerciale sur 2025 et 2026. Étude pivotale pour...

THERACLION CONFIRME SES RÉALISATIONS DU PREMIER SEMESTRE

Priorités : Accès au marché américain, R&D et Chine. Principales réalisations du premier semestre 2024 : Étude pivot de la FDA : traitements terminés en juin, comme prévu ; Progrès...

SONOVEIN® FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE) innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy...

Theraclion: SONOVEIN® Highlighted in Top Medical Conferences and Scientific Journal

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces that...

THERACLION MET À DISPOSITION SON RAPPORT FINANCIER 2023

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), société innovante développant une plateforme robotique pour la thérapie non invasive par ultrasons focalisés de haute intensité...

Theraclion Announces 2023 Financial Results and Continues Its Roadmap

Continuation of the strategy focused on access to the US and Chinese markets for SONOVEIN®, and its improvement through R&D; Rapid start-up of the pivotal study in the United States:...

Theraclion Announces Major Advances and Reports First-Half Financial Results

On the strength of its progress on its 2023 and 2024 priorities (access to the US market, R&D and China), Theraclion is planning its commercial ramp-up for 2025 and 2026. Pivotal study for...

THERACLION CONFIRME SES RÉALISATIONS DU PREMIER SEMESTRE

Priorités : Accès au marché américain, R&D et Chine. Principales réalisations du premier semestre 2024 : Étude pivot de la FDA : traitements terminés en juin, comme prévu ; Progrès...

SONOVEIN® FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE) innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy...

Theraclion: SONOVEIN® Highlighted in Top Medical Conferences and Scientific Journal

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces that...

THERACLION MET À DISPOSITION SON RAPPORT FINANCIER 2023

THERACLION ANNONCE SES RÉSULTATS FINANCIERS 2023 ET POURSUIT SA FEUILLE DE ROUTE

Poursuite de la stratégie centrée sur les accès aux marchés américain et chinois pour le SONOVEIN®, et à son amélioration grâce à la R&D ; Démarrage rapide de l’étude pivot aux Etats-Unis :...

Theraclion Pursues Its Strategy and Announces Its 2023 Revenue

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE), an innovative company developing a scalable robotic platform for non-invasive focused ultrasound therapy (HIFU...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.07	-17.4129353234	0.402	0.402	0.332	23969	0.3695206	DE
4	-0.034	-9.28961748634	0.366	0.46	0.325	17789	0.37636377	DE
12	-0.072	-17.8217821782	0.404	0.46	0.312	12478	0.3802561	DE
26	-0.015	-4.32276657061	0.347	0.46	0.286	25871	0.34652778	DE
52	-0.067	-16.7919799499	0.399	0.68	0.286	28286	0.38344006	DE
156	-0.933	-73.7549407115	1.265	1.625	0.286	20450	0.65834075	DE
260	-1.318	-79.8787878788	1.65	2.76	0.286	20535	1.07384539	DE

ALTHE - Frequently Asked Questions (FAQ)

What is the current Theraclion share price?

The current share price of Theraclion is 0.332 €

How many Theraclion shares are in issue?

Theraclion has 45,732,250 shares in issue

What is the market cap of Theraclion?

The market capitalisation of Theraclion is EUR 15.59M

What is the 1 year trading range for Theraclion share price?

Theraclion has traded in the range of 0.286 € to 0.68 € during the past year

What is the PE ratio of Theraclion?

The price to earnings ratio of Theraclion is -4.1

What is the cash to sales ratio of Theraclion?

The cash to sales ratio of Theraclion is 3.85

What is the reporting currency for Theraclion?

Theraclion reports financial results in EUR

What is the latest annual turnover for Theraclion?

The latest annual turnover of Theraclion is EUR 3.92M

What is the latest annual profit for Theraclion?

The latest annual profit of Theraclion is EUR -3.68M

What is the registered address of Theraclion?

The registered address for Theraclion is IMMEUBLE LE VAILLANT ,244 AVENUE PIERRE BROSSOLETTE, MALAKOFF, HAUTS-DE-SEINE, 92240

What is the Theraclion website address?

The website address for Theraclion is www.theraclion.com

Which industry sector does Theraclion operate in?

Theraclion operates in the MED, DENTAL, HOSP EQ-WHSL sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TMBSZTME Pharma NV	0.02 € (185.71%)	132.5k
MLGEQGentlemen S Equity SA	0.0175 € (118.75%)	1.14k
ALCYBCybergun	0.0002 € (100.00%)	17.54M
MLAAHAmatheon Agri Holding NV	0.0185 € (54.17%)	40.1k
ALARFAdeunis	0.94 € (28.77%)	5.27k
MLSMLSmalto	0.0125 € (-37.50%)	2.34k
MLFTIFrance Tourisme Immobilier	0.025 € (-35.90%)	56.77k
CNVCnova NV	0.209 € (-19.62%)	26.38k
MLWEAWeaccess Group	0.382 € (-16.96%)	5.95k
ALEUPEuroplasma	0.0353 € (-15.95%)	3.16M
ATOAtos SE	0.0021 € (0.00%)	2.71B
BCPBanco Comercial Portugues SA	0.4493 € (-0.69%)	66.54M
ALHGLouis Hachette Group	1.3342 € (4.87%)	52.04M
KPNKoninklijke KPN NV	3.509 € (-1.21%)	26.9M
VIVVivendi SE	2.51 € (2.41%)	26.39M